Short-read Sequencing Market

The global Short-read Sequencing market size was valued at US$ 12.34 billion in 2024 and is projected to reach US$ 22.67 billion by 2030, at a CAGR of 10.7% during the forecast period 2024-2030.

The United States Short-read Sequencing market size was valued at US$ 4.56 billion in 2024 and is projected to reach US$ 8.12 billion by 2030, at a CAGR of 10.1% during the forecast period 2024-2030.

Short-read Sequencing is a DNA sequencing technology that analyzes small fragments of DNA, primarily used in genomics research and clinical diagnostics.

The global Short-read Sequencing market is experiencing rapid growth, driven by research and clinical applications. In 2023, total sequencing volume reached 25 petabases, with research institutions accounting for 55% of demand. The clinical diagnostics segment is growing at 12.5% annually. The market saw a 30% increase in demand for high-throughput systems in 2023. Illumina platforms dominate with a 75% market share, while emerging technologies are growing at 15% annually. North America leads with a 40% market share, while Asia Pacific is the fastest-growing region at 12.8% CAGR. The industry is focusing on developing improved accuracy solutions, with a 35% growth in R&D investments.

Report Overview

Short-read Sequencing Market provides a deep insight into the global Short-read Sequencing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short-read Sequencing Market, Short-read Sequencing Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, Short-read Sequencing Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short-read Sequencing market in any manner.

Global Short-read Sequencing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Thermo Fisher Scientific
• Hoffmann-La Roche AG
• GE healthcare
• Fasteris SA
• BGI Genomics
• Agilent Technologies
• Genscript Biotech Corporation
• Macrogen
• Genewiz
• Qiagen
• Illumina

• Instruments
• Consumables
• Services

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other